Drug doubt
Statins do not benefit patients with lung cancer, new study shows
Cholesterol-lowering drugs used alongside chemotherapy have no effect on treatment outcomes for lung cancer patients, according to a new study.
Statins do not benefit patients with lung cancer, new study shows
Cholesterol-lowering drugs used alongside chemotherapy have no effect on treatment outcomes for lung cancer patients, according to a new study.
Eating more fruits and vegetables may prevent millions of premature deaths
A fruit and vegetable intake above five-a-day shows major benefit in reducing the chance of heart attack, stroke, cancer and early death.
18
Bowel scope cuts cancer risk for at least 17 years
A one-off screening test reduces the risk of developing bowel cancer by more than one third and could save thousands of lives, a study has found.
'Google Earth' of tumours may lead to more cancer treatments
Scientists have been awarded £16m to create a detailed map of a tumour, which will allow researchers to explore new treatment options.
Four ways Imperial is leading the fight against cancer
To coincide with World Cancer Day on 4 February, we look at how Imperial College London has been leading the fight against cancer in the past year.
2
Sun exposure at work could lead to one skin cancer death a week
Working in the sun could lead to one death and around five new cases of melanoma skin cancer a week, according to a new Imperial study.
7 times Imperial research made you double-take in 2016
Every now and again, a research story comes along which make you blink and look twice.
Cancer centres receive funding boost for research and treatment programmes
Lifesaving cancer research and treatment centres at Imperial have received a further five years of funding from Cancer Research UK.
Leading the way in patient and public engagement
Senior Research Nurse leads the way in engaging patients and the public in cancer research taking place at Imperial.
Feature
Mo money means more prostate cancer research at Imperial
Head of prostate cancer research at Imperial, Professor Charlotte Bevan explains how Movember has helped give the disease the attention it deserves.